Most Popular
-
1
Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
-
2
Wealthy parents ditch Korean passports to get kids into international school
-
3
Man convicted after binge eating to avoid military service
-
4
First snow to fall in Seoul on Wednesday
-
5
Final push to forge UN treaty on plastic pollution set to begin in Busan
-
6
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
7
Nvidia CEO signals Samsung’s imminent shipment of AI chips
-
8
Industry experts predicts tough choices as NewJeans' ultimatum nears
-
9
Job creation lowest on record among under-30s
-
10
Opposition chief acquitted of instigating perjury
Kang Stem Biotech earns patent for rheumatoid arthritis stem cell cure
By 정민경Published : July 20, 2016 - 10:41
[DISCLOSURE] Kang Stem Biotech (217730) announced on July 20 that it has earned patent rights for a pharmaceutical composition comprising stem cells treated with NOD2 agonist for immune disorders and inflammatory diseases such as rheumatoid arthritis.
